Melanoma survival boosted with new drug
A new drug to treat melanoma is boosting survival rates with some patients even being cured of skin cancer. Keytruda (pembrolizumab) helped four in 10 patients with advanced melanoma stay alive. Complete remission was also seen in 15 percent of patients and some remained cancer-free even after stopping Keytruda. Keytruda has seen some success as ...click here to read more






